Evidence map›Paper›PMID 33028681›Full record

ArticlemSphere2020

Phylogenetic and Evolutionary Analysis Reveals the Recent Dominance of Ciprofloxacin-Resistant Shigella sonnei and Local Persistence of S. flexneri Clones in India.

Dhiviya Prabaa Muthuirulandi Sethuvel, Ankur Mutreja, Agila Kumari Pragasam, Karthick Vasudevan, Dhivya Murugan, Shalini Anandan, Joy Sarojini Michael, Kamini Walia, Balaji Veeraraghavan

Abstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Healthcare (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Anti-virulence and bactericidal activities of Stattic againstApplied and environmental microbiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dhiviya Prabaa Muthuirulandi SethuvelDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Ankur MutrejaDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Agila Kumari PragasamDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Karthick VasudevanDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Dhivya MuruganDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Shalini AnandanDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Joy Sarojini MichaelDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Kamini WaliaDivision of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Balaji VeeraraghavanDepartment of Clinical Microbiology, Christian Medical College, Vellore, India vbalaji@cmcvellore.ac.in.ORCID 0000-0002-8662-4257

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Evolution, MolecularPhylogenyAnti-Bacterial AgentsCiprofloxacinDrug Resistance, Multiple, BacterialDysentery, BacillaryFecesGenome, BacterialHumansIndiaSerogroupShigella flexneriShigella sonneiWhole Genome SequencingAnti-Bacterial AgentsCiprofloxacinantimicrobial resistanceCentral Asia IIImultidrug resistancepangenomeShigella

Identifiers

PMID33028681
PMCPMC7568650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.